Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirsh

Showing results (1-10 of 2,959) with videos related to

Pageof 296
Sort By:
Journal of Thrombosis and Thrombolysis|January 1, 1997
Low-Molecular-Weight Heparin Should Replace Unfractionated Heparin for Treatment of Venous Thrombosis and Unstable AnginaHirsh
The Journal of Cardiovascular Management : the Official Journal of the American College of Cardiovascular Administrators|October 13, 2001
The not-so-dormant commerce clause: implications of the Quintiles-WebMD case for HIPAA preemptionR Hirsh
Anti-Cancer Agents in Medicinal Chemistry|August 26, 2011
Vera Hirsh
Seminars in Thrombosis and Hemostasis|January 1, 1986
Effectiveness of anticoagulantsJ Hirsh
JAMA|June 8, 1984
New approaches for deep vein thrombosis occurring after surgeryJ Hirsh
Haemostasis|October 1, 1996
Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of venous thrombosisJ Hirsh
Canadian Family Physician Medecin De Famille Canadien|May 15, 2010
Low dose heparin prophylaxisJ Hirsh
Advances in Pharmacology (San Diego, Calif.)|November 5, 1997
Decapitated Drosophila: a novel system for the study of biogenic aminesJ Hirsh
Seminars in Hematology|October 1, 1977
HypercoagulabilityJ Hirsh
BMJ (Clinical Research Ed.)|September 23, 2003
Male subfertilityAnthony Hirsh
Pageof 296

Showing results (1-10 of 2,959) with videos related to

Sort By:
Pageof 296
Journal of Thrombosis and Thrombolysis|January 1, 1997
Low-Molecular-Weight Heparin Should Replace Unfractionated Heparin for Treatment of Venous Thrombosis and Unstable AnginaHirsh
The Journal of Cardiovascular Management : the Official Journal of the American College of Cardiovascular Administrators|October 13, 2001
The not-so-dormant commerce clause: implications of the Quintiles-WebMD case for HIPAA preemptionR Hirsh
Anti-Cancer Agents in Medicinal Chemistry|August 26, 2011
Vera Hirsh
Seminars in Thrombosis and Hemostasis|January 1, 1986
Effectiveness of anticoagulantsJ Hirsh
JAMA|June 8, 1984
New approaches for deep vein thrombosis occurring after surgeryJ Hirsh
Haemostasis|October 1, 1996
Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of venous thrombosisJ Hirsh
Canadian Family Physician Medecin De Famille Canadien|May 15, 2010
Low dose heparin prophylaxisJ Hirsh
Advances in Pharmacology (San Diego, Calif.)|November 5, 1997
Decapitated Drosophila: a novel system for the study of biogenic aminesJ Hirsh
Seminars in Hematology|October 1, 1977
HypercoagulabilityJ Hirsh
BMJ (Clinical Research Ed.)|September 23, 2003
Male subfertilityAnthony Hirsh
Pageof 296